Europe (WHO region) vs Togo: Previously treated cases tested for RR-/MDR-TB
Europe (WHO region)
90.0%
in 2024
Togo
100.0%
in 2024
Europe (WHO region) rank
2nd
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Togo
How they compare
Togo currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Togo's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 10 times across 17 shared years of data; in 2007 it was Togo ahead.
Europe (WHO region) ranks 2nd and Togo ranks 1st of 11 groups.
Across the 3 decades both report, Europe (WHO region) averaged higher in 2 and Togo in 1.
Head to head by decade
| Decade | Europe (WHO region) | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.3% | 12.6% | 11.7% | Europe (WHO region) |
| 2010s | 59.6% | 61.3% | 1.8% | Togo |
| 2020s | 93.8% | 92.2% | 1.6% | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Europe (WHO region) or Togo?
- Togo, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Europe (WHO region) and Togo?
- 10.0%, with Togo ahead.
- How many years of comparable data are there for Europe (WHO region) and Togo?
- 17 years are reported by both, from 2007 to 2024.
- How do Europe (WHO region) and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 2nd and Togo ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.